All Clinical trials

Citations 451-460 of 604 total displayed.

Past content (since Jan 2000):

CLINICAL/SCIENTIFIC NOTES
Stuttering relieved by divalproex sodium: Laurentius J.M.M. Mulder and Egilius L.H. Spierings
Neurology 2003; 61: 714. [Full text] [PDF]

EDITORIALS
ALS treatment strikes out while trying for a homer: The topiramate trial: Petra Kaufmann and Catherine Lomen-Hoerth
Neurology 2003; 61: 434-435. [Full text] [PDF]

ARTICLES
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis: M.E. Cudkowicz, J.M. Shefner, D.A. Schoenfeld, R.H. Brown, Jr., H. Johnson, M. Qureshi, M. Jacobs, J.D. Rothstein, S.H. Appel, R.M. Pascuzzi, T.D. Heiman-Patterson, P.D. Donofrio, W.S. David, J.A. Russell, R. Tandan, E.P. Pioro, K.J. Felice, J. Rosenfeld, R.N. Mandler, G.M. Sachs, W.G. Bradley, E.M. Raynor, G.D. Baquis, J.M. Belsh, S. Novella, J. Goldstein, and J. Hulihan
Neurology 2003; 61: 456-464. [Abstract] [Full text] [PDF]

ARTICLES
Donepezil in vascular dementia: A randomized, placebo-controlled study: D. Wilkinson, R. Doody, R. Helme, K. Taubman, J. Mintzer, A. Kertesz, and R.D. Pratt
Neurology 2003; 61: 479-486. [Abstract] [Full text] [PDF]

BRIEF COMMUNICATIONS
A randomized controlled study of modified cobratoxin in adrenomyeloneuropathy: H.R. Mundy, S.J. Jones, J.C. Hobart, M.G. Hanna, and P.J. Lee
Neurology 2003; 61: 528-530. [Abstract] [Full text] [PDF]

BRIEF COMMUNICATIONS
Interrupted therapy: Stopping and switching of the ß-interferons prescribed for MS: Helen L. Tremlett and Joel Oger
Neurology 2003; 61: 551-554. [Abstract] [Full text] [PDF]

CLINICAL/SCIENTIFIC NOTES
Response to sumatriptan in headache of MELAS syndrome: Takahiro Iizuka, Fumihiko Sakai, Motoi Endo, and Norihiro Suzuki
Neurology 2003; 61: 577-578. [Full text] [PDF]

EDITORIALS
Nondopaminergic symptomatic therapies for Parkinson’s disease: Turn on or turn off?: Andrew Feigin
Neurology 2003; 61: 286-287. [Full text] [PDF]

ARTICLES
Adenosine A_2A receptor antagonist treatment of Parkinson’s disease: W. Bara-Jimenez, A. Sherzai, T. Dimitrova, A. Favit, F. Bibbiani, M. Gillespie, M.J. Morris, M.M. Mouradian, and T.N. Chase
Neurology 2003; 61: 293-296. [Abstract] [Full text] [PDF]

ARTICLES
Randomized trial of the adenosine A_2A receptor antagonist istradefylline in advanced PD: Robert A. Hauser, Jean P. Hubble, Daniel D. Truong, and the Istradefylline US-001 Study Group
Neurology 2003; 61: 297-303. [Abstract] [Full text] [PDF]

Collected Resources Home

HOME